Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Endocrine 2

Conditions

Postoperative Complications 1Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Hypopituitarism 1Dwarfism, Pituitary 1Atherosclerosis 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Growth Hormone × Clear all
NCT03717168 2019-08-21

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Postoperative Complications

NCT01853566 2014-09-03

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Universidade Federal do Rio de Janeiro

Phase 4 Completed
13 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT00462475 2007-10-16

5yrGH

Federico II University

Completed
20 enrolled
Endocrine

Dwarfism, Pituitary, Hypopituitarism, Pituitary Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡